Virology News and Research

Latest Virology News and Research

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

Depixus®, a biotechnology company, today announces it has raised EUR 30.6 million in an oversubscribed Series A financing.

From Depixus® 15 Dec 2021

A new rapid and inexpensive PCR method to detect SARS-CoV-2 Omicron variant

A new study reports a method using four PCR tests to distinguish infection with the Omicron variant from that caused by other variants.

12 Dec 2021

Vaccinated, previously-infected people could have some "stronger than basic" defense against Omicron variant

Published today, one of the earliest, peer-reviewed studies looking into the Omicron variant of COVID-19 suggests that people previously infected with COVID, and those vaccinated, will have some, "stronger than basic" defense against this new strain of concern.

12 Dec 2021

Kinetics and persistence of SARS-CoV-2 antibody responses

New study findings indicate that antibody detection shows a distinct pattern depending on the type of antibody detected, the target antigen, the test design, antibody avidity level, and COVID-19 severity.

9 Dec 2021

Study shows SARS-CoV-2 transmission in Ireland before first official COVID-19 report

New study findings showed evidence of SARS-CoV-2 dissemination in Ireland prior to the identification of the first official COVID-19 case.

8 Dec 2021

Sino Biological Launches A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529)

Sino Biological, Inc. (https://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus

From Sino Biological Inc. 6 Dec 2021

The emergence and evolution of SARS-CoV-2 and its VOCs

A review article discusses the evolution of SARS-CoV-2 and the emergence of variants of concern.

5 Dec 2021

Exposure to Chikungunya may offer partial cross-protection against Mayaro virus

A study conducted at the University of São Paulo (USP) in Brazil suggests people previously infected by Chikungunya virus may develop partial immunity to Mayaro virus.

4 Dec 2021

Glycosylation and disulfide bonding profile of SARS-CoV-2 spike glycoprotein

Researchers found that virus-like particles produced by co-expression of SARS-CoV-2 S, membrane, envelope, and nucleocapsid proteins contain S glycoproteins, which are modified by complex carbohydrates.

29 Nov 2021

Do we need COVID-19 vaccine boosters?

An article published recently in the Journal of Virology explored the science behind COVID-19 vaccine boosters.

29 Nov 2021

Discovering a new gene in monkeys that could help to develop new antivirals

We spoke to Dr. Nels Elde about his latest research that led to the discovery of a new gene in monkeys that could help to develop new antivirals.

26 Nov 2021

Strong antibody responses against harmless coronaviruses may protect against SARS-CoV-2

Infections with the novel coronavirus and vaccination lead to strong antibody responses against SARS-CoV-2. Immune responses to other human coronaviruses, which mostly only cause harmless colds, also provide some protection against SARS-CoV-2.

23 Nov 2021

Two-meter COVID-19 rule is not a concrete measurement of safety, say researchers

A new study has shown that the airborne transmission of COVID-19 is highly random and suggests that the two-meter rule was a number chosen from a risk 'continuum', rather than any concrete measurement of safety.

23 Nov 2021

Covid-19 could reduce the perception of pain in oncological patients

Physicians from the Geneva University Hospitals (HUG) have observed a surprising phenomenon during the second wave of the COVID-19 pandemic: some patients with cancer-related pain have experiences a significant decrease or even disappearance of pain perception during the acute phase of infection.

22 Nov 2021

Elusive white blood cells play a role in impaired T cell functions and counts in people with HIV

In a groundbreaking study of people living with HIV, University of Alberta researchers found that elusive white blood cells called neutrophils play a role in impaired T cell functions and counts, as well as the associated chronic inflammation that is common with the virus.

9 Nov 2021

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine and MitoPower LLC were awarded an SBIR (Small Business Innovation Research) grant of up to $6.5 million over five years from the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism.

9 Nov 2021

Pacific oyster as a weapon against SARS-CoV-2

According to an article published in the journal Reviews in Medical Virology, the effectiveness of mollusc-derived antiviral agents has been proven in many different laboratory and animal studies, while its efficacy against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been proposed by recent in silico studies.

7 Nov 2021

Fast evolution of SARS-CoV-2 driven by extensive RNA deamination by host cells

A new study proposed that the RNA structure and the genome component may serve as an important basis of different deamination spectrums in SARS-CoV-2.

7 Nov 2021

Antibody response of COVID-19 patients to SARS-CoV-2 and seasonal coronaviruses

Scientists conducted a cohort study and measured the prevalence and the levels of antibody responses to the nucleocapsid protein of SARS-CoV-2 and four seasonal human coronaviruses.

3 Nov 2021

New genetic epidemiology tool provides detailed information about viruses, coinfections

With mask wearing and social distancing on the decline and the cold and flu season upon us, researchers have developed a viral panel that enables the simultaneous testing for SARS-CoV-2 along with numerous common respiratory viruses, that tells us whether other viruses also are at play in patients hard hit by COVID.

1 Nov 2021

Virology News and Research

Latest Virology News and Research

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

A new rapid and inexpensive PCR method to detect SARS-CoV-2 Omicron variant

Vaccinated, previously-infected people could have some "stronger than basic" defense against Omicron variant

Kinetics and persistence of SARS-CoV-2 antibody responses

Study shows SARS-CoV-2 transmission in Ireland before first official COVID-19 report

Sino Biological Launches A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529)

The emergence and evolution of SARS-CoV-2 and its VOCs

Exposure to Chikungunya may offer partial cross-protection against Mayaro virus

Glycosylation and disulfide bonding profile of SARS-CoV-2 spike glycoprotein

Do we need COVID-19 vaccine boosters?

Discovering a new gene in monkeys that could help to develop new antivirals

Strong antibody responses against harmless coronaviruses may protect against SARS-CoV-2

Two-meter COVID-19 rule is not a concrete measurement of safety, say researchers

Covid-19 could reduce the perception of pain in oncological patients

Elusive white blood cells play a role in impaired T cell functions and counts in people with HIV

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

Pacific oyster as a weapon against SARS-CoV-2

Fast evolution of SARS-CoV-2 driven by extensive RNA deamination by host cells

Antibody response of COVID-19 patients to SARS-CoV-2 and seasonal coronaviruses

New genetic epidemiology tool provides detailed information about viruses, coinfections

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production